New York 2023-2024 Regular Session

New York Senate Bill S01267

Introduced
1/11/23  
Refer
1/11/23  
Report Pass
1/17/23  
Engrossed
1/17/23  
Refer
1/17/23  
Refer
1/3/24  
Engrossed
1/30/24  
Refer
1/30/24  
Engrossed
5/21/24  
Refer
5/21/24  
Engrossed
6/5/24  
Enrolled
12/12/24  
Chaptered
12/21/24  

Caption

Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.

Companion Bills

NY A00901

Same As Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.

Previously Filed As

NY A00901

Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.

NY SB765

Prohibiting step therapy protocols for certain cancer drugs.

NY AB774

Prohibiting step therapy protocols for certain cancer drugs.

NY H0721

Step-therapy Protocols

NY HB721

Step-therapy Protocols:

NY S0264

Step-therapy Protocols

NY S0070

Step-therapy Protocols

NY SB307

AN ACT relating to step therapy protocols.

NY HF743

Use of step therapy protocol prohibited for insulin drugs.

NY SF2071

Step therapy use protocol for insulin drugs prohibition

Similar Bills

No similar bills found.